AHG
Akso Health Group ADR
NASDAQ: AHG · HEALTHCARE · MEDICAL DISTRIBUTION
$2.11
-8.22% today
Updated 2026-06-05
Market cap
$1.70B
P/E ratio
—
P/S ratio
114.29x
EPS (TTM)
$-0.48
Dividend yield
—
52W range
$1 – $3
Volume
0.1M
WallStSmart proprietary scores
16
out of 100
Grade: F
Strong Sell
Investment rating
6.0
Growth
B7.5
Quality
B+2.5
Profitability
F6.0
Valuation
B2/9
Piotroski F-Score
Weak
7.3
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
$1.72
Margin of safety
+18.02%
Price chart
Stock snapshot
Strengths
+ Altman Z 7.29 — safe zone
+ Free cash flow $3.00M — positive
+ 18.02% below intrinsic value
+ Debt/equity 0.00x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Thin margins at 0.00%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $6.31M | $13.18M | $2.41M | $14.78M | $14.84M |
| Net income | $-16.85M | $-1.36M | $-9.46M | $-134.98M | $-67.20M |
| EPS | — | — | — | — | $-0.48 |
| Free cash flow | $-8.63M | $-3.26M | $1.35M | $1.02M | $3.00M |
| Profit margin | -266.99% | -10.32% | -391.78% | -913.38% | — |
Peer comparison
Smart narrative
Akso Health Group ADR trades at $2.11. Our Smart Value Score of 16/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 7.29, it sits in the safe zone. TTM revenue stands at $14.84M. Our DCF model estimates intrinsic value at $1.72.
Frequently asked questions
What is Akso Health Group ADR's stock price?
Akso Health Group ADR (AHG) trades at $2.11, on a P/S of 114.3x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Akso Health Group ADR overvalued?
Akso Health Group ADR carries a Smart Value Score of 16/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $1.72 versus the $2.11 price, a 18.0% margin of safety on a cash flow basis.
What is the intrinsic value of Akso Health Group ADR (AHG)?
Our DCF model estimates intrinsic value at $1.72, a +18.0% margin of safety versus today's $2.11. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is Akso Health Group ADR's revenue?
Akso Health Group ADR's trailing twelve-month revenue is $14.84M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Akso Health Group ADR's Altman Z-Score is 7.29, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL DISTRIBUTION
CountryChina
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio114.29x
ROE-69.43%
Beta-0.90
50D MA$2.14
200D MA$1.71
Shares out0.85B
Float2.56B
Short ratio—
Avg volume0.1M
Performance
1 week-1.28%
1 month+60.95%
3 months+41.46%
YTD+41.46%
1 year—
3 years—
5 years—